HGB

EQS-News: InCity Immobilien AG: WITH A CONSOLIDATED LOSS OF EUR 2.9 M ACC. TO HGB, INCITY’S ON TARGET FOR 2022 – CONTINUED HIGH HIDDEN RESERVES IN THE PORTFOLIO

Retrieved on: 
Friday, April 28, 2023
Saskatchewan River Sturgeon Management Board, Tour Incity, MBH, Life, Bank statement, Policy, COVID-19, NAV, Tenant, Amortising swap, Sale, LTV, EBITDA, Acquisition, Investment, Depreciation, HGB, Annual report, Bank, Real estate, Lithium, Cryptocurrency, EUR

TO HGB, INCITY’S ON TARGET FOR 2022 – CONTINUED HIGH HIDDEN RESERVES IN THE PORTFOLIO

Key Points: 
  • TO HGB, INCITY’S ON TARGET FOR 2022 – CONTINUED HIGH HIDDEN RESERVES IN THE PORTFOLIO
    The issuer is solely responsible for the content of this announcement.
  • TO HGB, INCITY’S ON TARGET FOR 2022 – CONTINUED HIGH HIDDEN RESERVES IN THE PORTFOLIO
    Schönefeld, 27 April 2022 – The annual report of InCity Immobilien AG (“InCity AG”) published today reports a net loss (acc.
  • to HGB) of EUR 2.9 m at Group level and a net loss of EUR 1.9 m at single-entity annual financial statement level for fiscal year 2022.
  • These amounted to approximately EUR 6.9 m after around EUR 6.7 m in the prior year.

EQS-News: action press AG: Fiscal year 2022: Preliminary annual results for 2022, restructuring of the group fully completed, slight increase in sales, synergy effects to take effect from 2023 onwards

Retrieved on: 
Wednesday, April 26, 2023
WKN, Bank statement, Tax, AG, Frankfurt, Gesellschaft mit beschränkter Haftung, Acquisition, Earnings before interest, taxes, depreciation and amortization, ISIN, HGB, News, Commercial code, Security (finance), Cryptocurrency

action press AG: Fiscal year 2022: Preliminary annual results for 2022, restructuring of the group fully completed, slight increase in sales, synergy effects to take effect from 2023 onwards

Key Points: 
  • action press AG: Fiscal year 2022: Preliminary annual results for 2022, restructuring of the group fully completed, slight increase in sales, synergy effects to take effect from 2023 onwards
    The issuer is solely responsible for the content of this announcement.
  • This was primarily due to profit transfers and group allocations with the two subsidiaries action press international GmbH and ddp media GmbH.
  • As much as 2022 went as expected, the synergy effects of the reorganization are having an impact: so far, fiscal 2023 has been profitable.
  • With around 160 million photos (as of October 2022), action press is one of the largest image databases in the world.

Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria

Retrieved on: 
Tuesday, April 25, 2023
Health, Clinical Trials, General Health, Research, Pharmaceutical, Science, Myelodysplastic syndrome, Omeros, Hemolysis, Paroxysmal nocturnal hemoglobinuria, Half-life, AMD, Hemoglobin, Aplastic anemia, Clinical trial, LDH, Geographic atrophy, Multimedia, Disorder, Corporation, HGB, Iron deficiency, Patient, Physician, Risk, PNH, Hematology, Aristotle University of Thessaloniki, Observation, Kidney disease, Disease, Pharmaceutical industry, Surveying, C3

To date, all patients have received only the lowest subcutaneous dose of OMS906 in this multidose trial.

Key Points: 
  • To date, all patients have received only the lowest subcutaneous dose of OMS906 in this multidose trial.
  • This single-arm, open-label clinical trial is evaluating the effect of once-monthly subcutaneous administration of OMS906 in patients with PNH.
  • OMS906 is Omeros’ lead investigational humanized monoclonal antibody targeting MASP-3, the key and most upstream activator of the alternative pathway of complement.
  • “We are excited by the data resulting from this trial of treatment-naïve patients,” said Gregory A. Demopulos, M.D., Omeros’ chairman and chief executive officer.

EQS-News: Cantourage Group SE: Strong revenue growth in 2022 and Q1 2023 based on preliminary figures

Retrieved on: 
Saturday, April 15, 2023
Bank statement, Dronabinol, Pharmacist, Patient, ISIN, Cannabis, SE, HGB, Commercial code, Drug

Berlin, 14 April 2023 – Cantourage Group SE (hereafter “Cantourage”, ISIN: DE000A3DSV01), a leading European producer and distributer of cannabis-based medicinal products, generated revenues of approximately EUR 14 million* in the 2022 fiscal year (2021: EUR 5.2 million), on the basis of preliminary and unaudited figures.

Key Points: 
  • Berlin, 14 April 2023 – Cantourage Group SE (hereafter “Cantourage”, ISIN: DE000A3DSV01), a leading European producer and distributer of cannabis-based medicinal products, generated revenues of approximately EUR 14 million* in the 2022 fiscal year (2021: EUR 5.2 million), on the basis of preliminary and unaudited figures.
  • Furthermore, also based on preliminary figures, Cantourage increased revenues in Q1 2023 by more than 95 % year-on-year.
  • Cantourage forms partnerships with cannabis cultivators worldwide, imports their cannabis flowers and processes them into medicinal products in Germany.
  • The pro forma financial information shows a hypothetical consolidation of the Cantourage Group and future financial information may differ from the pro forma information.

EQS-News: H&R GmbH & Co. KGaA confirms preliminary figures and publishes Annual Report 2022

Retrieved on: 
Saturday, April 15, 2023
Annual, EUR, HGB, EBITDA, Frankfurt Stock Exchange, Annual report, Publication, Bank statement, Commercial code, Fine chemical

H&R GmbH & Co. KGaA has achieved distributable earnings in accordance with the German Commercial Code (HGB) for 2022.

Key Points: 
  • H&R GmbH & Co. KGaA has achieved distributable earnings in accordance with the German Commercial Code (HGB) for 2022.
  • The management will propose to the Annual General Meeting to distribute a dividend of EUR 0.10 per share.
  • For a complete presentation of the business development including the segment reporting and the annual financial statements, H&R KGaA refers to the Annual Report 2022, which is published today at www.hur.com - Investors - Publications.
  • H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment.

EQS-News: MEDIQON Group AG: Group growth continued again in the 2022 financial year and a successful start to the 2023 financial year

Retrieved on: 
Saturday, April 15, 2023
Financial Oversight and Management Board for Puerto Rico, Bank statement, Supervisory board, AG, EBITDA, Acquisition, Base, Depreciation, Growth, HGB, Amortization calculator, News, Commercial code, Security (finance), Cryptocurrency, Lithium, EUR

At the end of 2022, the group encompassed a total of 26 operating companies, two of which were minority holdings.

Key Points: 
  • At the end of 2022, the group encompassed a total of 26 operating companies, two of which were minority holdings.
  • The proportion of this attributable to MEDIQON Group AG is around EUR 11.1 million.
  • Liquid funds, including the securities portfolio at MEDIQON Group AG level, amounted to around EUR 54.4 million as of December 31, 2022.
  • Liquid funds, including the securities portfolio at MEDIQON Group AG level, amounted to around EUR 29.9 million as of April 14, 2023.

EQS-News: Neon Equity AG: Invitation to the Annual General Meeting on May 10, 2023

Retrieved on: 
Saturday, April 15, 2023
Krishna River Management Board, Bank statement, Annual, Supervisory board, EBIT, Equity, Frankfurt, EUR, Federal Executive Boards, ISIN, HGB, Neon, Life insurance, Security (finance)

Neon Equity AG: Invitation to the Annual General Meeting on May 10, 2023

Key Points: 
  • Neon Equity AG: Invitation to the Annual General Meeting on May 10, 2023
    The issuer is solely responsible for the content of this announcement.
  • Neon Equity AG: Invitation to the Annual General Meeting on May 10, 2023
    Frankfurt am Main, April 3, 2023 - Neon Equity AG (Neon Equity; ISIN: DE000A3DW408), a founder-led investor and growth enabler, invites to its first Annual General Meeting on May 10, 2023 at 11 am.
  • The capital increase is to be implemented by issuing 4,005,010 new registered no-par value shares with a notional interest in the share capital of EUR 1.00 per share (so-called bonus shares).
  • Furthermore, the Executive Board and the Supervisory Board propose to the Annual General Meeting, among other things, that the unappropriated profit for the financial year 2022 in the amount of EUR 200,811,446.00 be carried forward in full to new account.

EQS-News: 2G Energy AG boosts EBIT by 23 % to EUR 22.0 million in 2022 according to preliminary figures (previous year: EUR 17.9 million)

Retrieved on: 
Friday, March 31, 2023
Saskatchewan River Sturgeon Management Board, Housing, Hydrogen, Frankfurt Stock Exchange, Agriculture, Electricity, Service, CHP, EBIT, Wind, Natural Resources, EUR, Natural gas, ISIN, Growth, London's New Year's Day Parade, HGB, Annual report, Conference, Renewable energy, Energy

The staff cost ratio dropped to 16.8 % in the past financial year (previous year: 18.4 %; relative to total turnover).

Key Points: 
  • The staff cost ratio dropped to 16.8 % in the past financial year (previous year: 18.4 %; relative to total turnover).
  • 2G will publish its audited consolidated financial statements and its 2022 annual report on April 27.
  • The 2G Energy AG Group is an internationally leading manufacturer of decentralized energy supply systems.
  • The shares of 2G Energy (ISIN DE000A0HL8N9) are listed in the “Scale” segment of the Frankfurt Stock Exchange.

EQS-News: DFV Deutsche Familienversicherung AG: Profit above expectations and above-average growth

Retrieved on: 
Friday, March 31, 2023
Saskatchewan River Sturgeon Management Board, IPO, Corporate sustainability, Marketing, German, Annual, Tax, Supervisory board, Federal Financial Supervisory Authority, EUR, GRI, Annual report, CSRD, OPEX, HGB, Environment, Lithium, Airline, Cryptocurrency

The (re-)achievement of profitability with continued above-average growth is a good basis for continuing profitability as a digital listed direct insurer in 2023 and the following years with consistent growth," comments Dr Stefan Knoll, CEO and founder of Deutsche Familienversicherung.

Key Points: 
  • The (re-)achievement of profitability with continued above-average growth is a good basis for continuing profitability as a digital listed direct insurer in 2023 and the following years with consistent growth," comments Dr Stefan Knoll, CEO and founder of Deutsche Familienversicherung.
  • Furthermore, Deutsche Familienversicherung plans to carry out a sustainability rating for the first time in 2023.
  • For 2023, Deutsche Familienversicherung plans to consistently continue its strategy of profitable growth.
  • Deutsche Familienversicherung has been applying the IFRS 9 accounting standard since 1 January 2023, which will bring increased earnings volatility.

EQS-News: TTL Beteiligungs- und Grundbesitz-AG: TTL publishes Annual Report 2022

Retrieved on: 
Tuesday, March 28, 2023
Carlyle, Particular, Partnership, VIB, Annual, Tax, TTL, Sale, EUR, RTÉ Executive Board, Acquisition, Supervisory board, ISIN, Depreciation, HGB, Environment, DIC, Security (finance), Real estate

TTL Beteiligungs- und Grundbesitz-AG ("TTL AG", "TTL") (ISIN DE0007501009) published its financial results for the year 2022 on 28 March 2023.

Key Points: 
  • TTL Beteiligungs- und Grundbesitz-AG ("TTL AG", "TTL") (ISIN DE0007501009) published its financial results for the year 2022 on 28 March 2023.
  • TTL Real Estate GmbH, in which TTL holds 50 percent of the shares, has further increased its stake in DIC Asset AG - from 7.95 percent to 8.22 percent.
  • "2022 was an extremely challenging year and TTL was effected by the developments in the commercial real estate market.
  • For TTL AG, the Executive Board expects a positive annual result of EUR 1.0 to 1.5 million, with an investment result at the level of 2022 of around EUR 2.5 to 3 million.